D. Dale

G. Lyman, V. Sivasubramaniam, J. Crawford, 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Reduced Relative Dose Intensity (RDI) in Patients with Aggressive Non-Hodgkin’s Lymphoma (NHL).

G. Lyman, J. Crawford, D. Dale, 2004 .

Eosinophil kinetics in the hypereosinophilic syndrome.

A. Fauci, D. Dale, R. Hubert, 1976, The Journal of laboratory and clinical medicine.

The Influence of Colony-Stimulating Factors on Neutrophil Production, Distribution, and Function

W. Liles, D. Dale, J. Gaviria, 1999 .

Retraction. Neutrophil elastase mutations in severe congenital neutropenia patients of the original Kostmann family.

J. Palmblad, B. Fadeel, D. Dale, 2003, Blood.

Intersections of hematology, immunology, dermatology and infectious diseases.

D. Dale, 2015, Current opinion in hematology.

A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices

J. Crawford, D. Dale, R. Rifkin, 2022, Supportive Care in Cancer.

Current Opinion in Hematology

T. Stossel, D. Dale, 2010 .

Infectious diseases : the clinician's guide to diagnosis, treatment, and prevention

D. Dale, 2003 .

Results of a Phase 2 Trial of an Oral CXCR4 Antagonist Mavorixafor for Treatment of WHIM Syndrome.

V. Garg, Honghua H. Jiang, D. Dale, 2020, Blood.

Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor

J. Kurtzberg, K. Welte, D. A. Weinstein, 2019, Current opinion in hematology.

The discovery, development and clinical applications of granulocyte colony-stimulating factor.

D. Dale, 1998, Transactions of the American Clinical and Climatological Association.

RENEWED INTEREST IN GRANULOCYTE TRANSFUSION THERAPY

W. Liles, D. Dale, T. Price, 1997, British journal of haematology.

Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist.

B. Wood, H. Broxmeyer, G. Bridger, 2004, Supportive cancer therapy.

Gene transfer in baboons using prosthetic vascular grafts seeded with retrovirally transduced smooth muscle cells: a model for local and systemic gene therapy.

A. Clowes, D. Dale, W. Osborne, 1994, Human gene therapy.

CYTOKINES IN THE TREATMENT OF INFECTION

D. Dale, 1997 .

Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with granulocyte–colony‐stimulating factor

W. Liles, D. Dale, T. Price, 2005, Transfusion.

Combined administration of G–CSF and dexamethasone for the mobilization of granulocytes in normal donors: optimization of dosing

W. Liles, D. Dale, E. Rodger, 2000, Transfusion.

Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte‐colony‐stimulating factor and dexamethasone

W. Liles, D. Dale, T. Price, 1998, Transfusion.

Long-term outcomes of myeloid growth factor treatment.

G. Lyman, D. Dale, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Use of prophylactic pegfilgrastim for chemotherapy-induced neutropenia in the US: A review of adherence to present guidelines for usage.

J. Crawford, V. Morrison, D. Dale, 2021, Cancer treatment and research communications.

Clinical Applications of G-CSF and GM-CSF in the Treatment of Infectious Diseases

W. Liles, D. Dale, K. Hübel, 2003 .

Granulocyte transfusion therapy: a new era?

D. Dale, T. Price, 2009, Current opinion in hematology.

Eosinophilic leukemia. Remission with vincristine and hydroxyurea.

D. Dale, M. Chusid, 1975, The American journal of medicine.

Twenty years of the colony-stimulating factors.

D. Dale, 2012, Current opinion in hematology.

Neutrophil biology and the next generation of myeloid growth factors.

D. Dale, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Complications and costs associated with febrile neutropenia in hospitalized adult cancer patients

G. Lyman, J. Crawford, D. Dale, 2004 .

Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases.

D. Dale, David C. Dale, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Lineage-specific hematopoietic growth factors.

P. Rosenberg, B. Alter, D. Dale, 2006, The New England journal of medicine.

Prednisone dose in alternate day therapy

A. Fauci, S. Wolff, D. Dale, 1975 .

Cyclic neutropenia: natural history and effects of long-term treatment with recombinant human granulocyte colony-stimulating factor.

D. Dale, W. Hammond, A. Bolyard, 1993, Cancer investigation.

Meta-analysis of prophylactic granulocyte colony-stimulating factor (G-CSF) in cancer patients receiving chemotherapy

G. Lyman, J. Crawford, D. Dale, 2005 .

The clinical examination revisited

D. Dale, 1993, Journal of General Internal Medicine.

rHUG-CSF for the treatment of severe chronic neutropenia

D. Dale, A. Bolyard, 2012 .

Tracers for tracing neutrophils.

D. Dale, 2016, Blood.

Kinetics of tumor-induced murine neutrophilia.

D. Dale, C. Finch, M. Lee, 1979, Blood.

Neutrophil transfusion: effect of storage and of collection method of neutrophil blood kinetics.

D. Dale, T. Price, 1978, Blood.

Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens.

W. Liles, D. Dale, R. Bowden, 1997, The Journal of infectious diseases.

Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo.

W. Liles, D. Dale, J. V. van Burik, 1999, The Journal of infectious diseases.

Myeloid growth factors. Clinical practice guidelines in oncology.

J. Armitage, G. Demetri, G. Lyman, 2007, The Journal of the National Comprehensive Cancer Network.

Understanding, Treating and Avoiding Hematological Disease: Better Medicine Through Mathematics?

M. Mackey, D. Dale, 2014, Bulletin of Mathematical Biology.

Effect of endotoxin on serum granulocyte and granulocyte-macrophage colony-stimulating factor levels in dogs.

T. Boone, D. Dale, W. Osborne, 1992, The Journal of infectious diseases.

Granulocyte (neutrophil) transfusion therapy

W. Liles, D. Dale, K. Hübel, 2003 .

Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.

G. Lyman, J. Crawford, D. Dale, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The phagocytes: neutrophils and monocytes.

W. Liles, D. Dale, L. Boxer, 2008, Blood.

Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.

D. Dale, W. Hammond, T. Price, 1989, The New England journal of medicine.

Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models.

M C Mackey, M. Mackey, D. Dale, 1998, Blood.

Association Between Absolute Neutrophil Count and Variation at TCIRG1: The NHLBI Exome Sequencing Project

A. Reiner, D. Nickerson, Joshua D. Smith, 2016, Genetic epidemiology.

Glucocorticoids inhibit apoptosis of human neutrophils.

W. Liles, W. Liles, D. Dale, 1995, Blood.

Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.

P G Mori, M. Freedman, K. Welte, 2000, Blood.

Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia.

E. Chi, W. Liles, D. Dale, 2001, Blood.

Human Cyclic Neutropenia: Clinical Review and Long-Term Follow-up of Patients

A. Fauci, S. Wolff, D. Dale, 1981, Medicine.

The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.

R Storb, E D Thomas, R. Storb, 1993, Blood.

Molecular basis and therapy of disorders associated with chronic neutropenia

D. Dale, S. Stein, 2003, Current allergy and asthma reports.

Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors

Michael Boeckh, Kai Hübel, M. Boeckh, 2002, Transfusion.

The cost effectiveness of therapeutic and prophylactic leukocyte transfusion.

E. Larson, D. Dale, T. Price, 1980, The New England journal of medicine.

Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.

W. Liles, D. Dale, J. V. van Burik, 1999, The Journal of infectious diseases.

Defective polymorphonuclear leukocyte metabolism and function in canine cyclic neutropenia.

D. Dale, M. Chusid, J. Bujak, 1975, Blood.

Cyclic hematopoiesis: the mechanism of cyclic neutropenia in grey collie dogs.

D. Alling, S. Wolff, D. Dale, 1972, The Journal of clinical investigation.

Experimental Pseudomonas pneumonia in leukopenic dogs: comparison of therapy with antibiotics and granulocyte transfusions.

J. Pennington, D. Dale, H. Reynolds, 1976, Blood.

Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of colllection method, donor corticosteroid treatment, and short-term storage.

D. Dale, T. Price, 1979, Blood.

Severe congenital neutropenia.

K. Welte, D. Dale, David C Dale, 2006, Seminars in hematology.

The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report.

Laurence Boxer, M. Freedman, K. Welte, 2006, Supportive cancer therapy.

Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.

C Bos, R. Person, K. Welte, 2000, Blood.

Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis

David C. Dale, R. Person, M. Horwitz, 1999, Nature Genetics.

Introduction to the hematopoietic growth factors.

G. Lyman, D. Dale, 2011, Cancer treatment and research.

Hematopoietic progenitors and aging

G. Chatta, D. Dale, W. Hammond, 1993 .

Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics

W. Chung, M. Watson, S. B. Wechsler, 2014, Genetics in Medicine.

Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia Studies investigating combination therapy of a beta-lactam with an aminoglycoside in animals with neutropenia

D. Dale, C. Cordonnier, H. Reynolds, 2008 .

Elastase inhibitors as potential therapies for ELANE‐associated neutropenia

D. Dale, A. Bolyard, A. A. Aprikyan, 2017, Journal of leukocyte biology.

CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients

K. Welte, K. Hipp, Yun Xu, 2019, Haematologica.

The diversity of mutations and clinical outcomes for ELANE-associated neutropenia

P. Rosenberg, P. Newburger, D. Link, 2015, Current opinion in hematology.

Guidelines for pediatric management of severe chronic neutropenia

D. Dale, L. Boxer, 2012, American journal of hematology.

Small Molecule Inhibitor of Neutrophil Elastase Restores Impaired Production of Human Myeloid Cells Observed in Severe Congenital Neutropenia.

R. Abagyan, M. Totrov, D. Dale, 2007 .

Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis.

Jun Xia, David Dale, D. Link, 2006, Blood.

A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

J. Gabrilove, A. Nakanishi, J. Kurtzberg, 1993, Blood.

Hematopoietic dynamics in grey collies.

M. C. Mackey, D. Dale, C Haurie, 1999, Experimental hematology.

Inherited Neutrophil Disorders: Molecular Basis and New Therapies.

M. Dinauer, D. Dale, J. Lekstrom-Himes, 2000, Hematology. American Society of Hematology. Education Program.

Studies of neutrophil production and turnover in grey collie dogs with cyclic neutropenia.

S. Wolff, D. Dale, S M Wolff, 1972, The Journal of clinical investigation.

Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome

Nicholas D. Camarda, S. Carter, M. Norkin, 2021, Nature Communications.

Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry.

A. Shimamura, K. Myers, S. Davies, 2014, The Journal of pediatrics.

Human cyclic hematopoiesis is associated with aberrant purine metabolism.

D. Dale, W. Hammond, W. Osborne, 1985, The Journal of laboratory and clinical medicine.

Supplying neutrophils from the bone marrow to the tissues

D. Dale, 2006 .

Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.

J. Griggs, G. Lyman, J. Crawford, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

arising in the setting of severe congenital neutropenia Distinct patterns of mutations occurring in de novo AML versus AML

E. Mardis, C. Bloomfield, M. McLellan, 2013 .

Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.

R. Wilson, E. Mardis, M. Caligiuri, 2007, Blood.

Granulocyte transfusion therapy: update on potential clinical applications

W. Liles, D. Dale, K. Hübel, 2001, Current opinion in hematology.

Granulocyte transfusion therapy of experimental Pseudomonas pneumonia.

J. Pennington, D. Dale, H. Reynolds, 1974, The Journal of clinical investigation.

Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor

P. Newburger, D. Dale, A. Bolyard, 2022, Blood Advances.

Colony-Stimulating Factors for the Management of Neutropenia in Cancer Patients

David C. Dale, D. Dale, 2002, Drugs.

Return of granulocyte transfusions.

W. Liles, D. Dale, 2000, Current opinion in pediatrics.

International forum: granulocyte transfusions.

R. Strauss, S. Devereux, P. Höcker, 2000, Vox sanguinis.

Periodic hematopoiesis in human cyclic neutropenia.

S Perry, D Guerry, S. Perry, 1973, The Journal of clinical investigation.

Gentamicin sulfate pharmacokinetics: lower levels of gentamicin in blood during fever.

J. Maclowry, J. Pennington, D. Dale, 1975, The Journal of infectious diseases.

Experimental pneumonia due to Pseudomonas in dogs: controlled trial of granulocyte transfusion therapy.

J. Pennington, D. Dale, H. Reynolds, 1974, The Journal of infectious diseases.

Studies of the neutropenia of acute malaria.

S. Wolff, D. Dale, 1973, Blood.

precursors by accelerated apoptosis and defective expression ofbcl-x in neutrophil Myelokathexis, a congenital disorder of severe neutropenia characterized

E. Chi, W. Liles, D. Dale, 2013 .

Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors.

E. Chi, W. Liles, D. Dale, 2000, Blood.

precursors in neutrophil bcl-x by accelerated apoptosis and defective expression of Myelokathexis , a congenital disorder of severe neutropenia characterized

E. Chi, W. Liles, D. Dale, 1999 .

Fever of undetermined origin

R. Petersdorf, P. Beeson, E. Larson, 1982 .

Poor prognosis in elderly patients with cancer: the role of bias and undertreatment.

D. Dale, 2003, The journal of supportive oncology.

Correction of human cyclic neutropenia with prednisolone.

A. Fauci, S. Wolff, D. Dale, 1978, The New England journal of medicine.

Neutropenia in Barth syndrome: characteristics, risks, and management

M. Mackey, R. Newbury-Ecob, D. Dale, 2019, Current opinion in hematology.

Recent progress in understanding the congenital neutropenias.

D. Dale, 2010, Current opinion in hematology.

Editorial: myeloid biology issue 2018.

D. Dale, 2018, Current opinion in hematology.

Distribution of granulocytopoietic committed stem cells in mice with tumor induced neutrophilia.

D. Dale, M. Lee, A. Sperlin, 1980, Experimental Hematology.

Cyclic neutropenia.

D. Dale, A. Bolyard, A. Aprikyan, 2002, Seminars in hematology.

Cyclic neutropenia: a clinical review.

D. Dale, W. Hammond, D C Dale, 1988, Blood reviews.

Lithium therapy of canine cyclic hematopoiesis

D. Dale, W. Hammond, 1980 .

Application of Time Series Analysis to Serial Blood Neutrophil Counts in Normal Individuals and Patients Receiving Cyclophosphamide

D. Alling, S. Wolff, D. Dale, 1973, British journal of haematology.

A comparison of treatment of canine cyclic hematopoiesis with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF interleukin-3, and canine G-CSF.

T. Boone, R. Donahue, D. Dale, 1990, Blood.

Hematopoietic progenitors in cyclic neutropenia: effect of granulocyte colony-stimulating factor in vivo.

A. Migliaccio, G. Migliaccio, D. Dale, 1990, Blood.

Mutant elastase in pathogenesis of cyclic and severe congenital neutropenia.

W. Liles, D. Dale, L. Boxer, 2002, Journal of pediatric hematology/oncology.

Antineutrophil Antibodies Lead to Mistaken Identity in Severe Congenital Neutropenia.

K. Welte, B. Alter, D. Dale, 2005 .

TCIRG1‐Associated Congenital Neutropenia

D. Nickerson, Joshua D. Smith, M. Bamshad, 2014, Human mutation.

Variable Clinical Presentation of Shwachman-Diamond Syndrome: Update From the North-American Shwachman-Diamond Syndrome Registry.

Nicholas J. Dobbins, A. Shimamura, K. Myers, 2012 .

Modeling complex neutrophil dynamics in the grey collie.

M. C. Mackey, R. Rudnicki, D. Dale, 2000, Journal of theoretical biology.

Clinical implications of mutations of neutrophil elastase in congenital and cyclic neutropenia.

W. Liles, D. Dale, D. Garwicz, 2001, Journal of pediatric hematology/oncology.

Cyclic thrombocytopenia with statistically significant neutrophil oscillations

M. Mackey, B. Leber, D. Dale, 2018, Clinical case reports.

A case report of cyclic thrombocytopenia with statistically significant neutrophil oscillations

M. Mackey, B. Leber, D. Dale, 2017 .

How I diagnose and treat neutropenia

D. Dale, 2016, Current opinion in hematology.

Stable long‐term risk of leukaemia in patients with severe congenital neutropenia maintained on G‐CSF therapy

Philip S Rosenberg, Akiko Shimamura, P. Rosenberg, 2010, British journal of haematology.

Human cyclic neutropenia: urinary colony-stimulating factor and erythropoietin levels.

J. Adamson, S. Wolff, D. Dale, 1974, Blood.

severe congenital neutropenia receiving long-term G-CSF therapy The incidence of leukemia and mortality from sepsis in patients with

P. Rosenberg, M. Freedman, K. Welte, 2013 .

Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia.

M. Albitar, D. Dale, S. Culbert, 2000, Blood.

Congenital and Acquired Chronic Neutropenias: Challenges, Perspectives and Implementation of the EuNet-INNOCHRON Action

J. Palmblad, K. Stamatopoulos, C. Mecucci, 2020, HemaSphere.

Is There a Role for Anti-Neutrophil Antibody Testing in Predicting Spontaneous Resolution of Neutropenia in Young Children

P. Newburger, D. Dale, L. Boxer, 2015 .

Cyclic Neutropenia, Congenital and Idiopathic Neutropenia

P. Newburger, D. Dale, A. Bolyard, 2017 .

The selective neutropenias.

D. Dale, T. Price, 1978, Clinics in haematology.

Update On the Risk of Leukemia in Genetic Subgroups of Congenital Neutropenia (CN): Comparison of Patients with Known Gene Mutations (ELA2, HAX1, WASP, G6PC3, p14).

C. Klein, D. Link, K. Welte, 2009 .

Introduction: severe chronic neutropenia.

D. Dale, 2002, Seminars in hematology.

An update on the diagnosis and treatment of chronic idiopathic neutropenia

D. Dale, A. Bolyard, 2017, Current opinion in hematology.

RUNX1 Mutations Are the Most Frequent Leukemia Associated Mutations in Congenital Neutropenia Patients

D. Steinemann, A. Kohlmann, S. Schnittger, 2012 .

Clinical Outcomes for Patients with Severe Chronic Neutropenia Due to Mutations in the Gene for Neutrophil Elastase, ELANE

Repository, P. Newburger, K. Welte, 2012 .

Hematopoietic growth factors for the treatment of severe chronic neutropenia

D. Dale, 1995, Stem cells.

Non-malignant neutropenia.

D. Dale, E. Sievers, 1996, Blood reviews.

Use of Granulocyte Colony-Stimulating Factor During Pregnancy in Women With Chronic Neutropenia

P. Newburger, D. Dale, L. Boxer, 2015, Obstetrics and gynecology.

Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers.

R. Allen, G. Chatta, D. Dale, 1994, Blood.

Heterozygous Variants of CLPB are a Cause of Severe Congenital Neutropenia.

D. Spencer, D. Link, A. Locke, 2021, Blood.

Cloxacillin chemoprophylaxis in the Chediak-Higashi syndrome.

D. Alling, S. Wolff, D. Dale, 1972, The Journal of infectious diseases.

Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy

G. Lyman, J. Crawford, D. Dale, 2011, Cancer.

Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review.

G. Lyman, J. Crawford, D. Dale, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immune and idiopathic neutropenia

D. Dale, 1998, Current opinion in hematology.

Chronic thrombocytopenia is induced in dogs by development of cross-reacting antibodies to the MpL ligand.

D. Dale, S. Slichter, W. Sheridan, 1997, Blood.

Therapeutic Use of Granulocyte Colony-Stimulating Factors for Established Febrile Neutropenia

G. Lyman, J. Crawford, L. Cosler, 2012, PharmacoEconomics.

Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.

J. Friedberg, R. Fisher, G. Lyman, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Updated ASCO recommendations for the use of white blood cell growth factors.

D. Dale, 2006, Clinical advances in hematology & oncology : H&O.

Crawford J, Dale DC, Lyman GH. Chemotherapy‐induced neutropenia: risks, consequences, and new directions for its management. Cancer. (2004) 100(2):228–37.

G. Lyman, J. Crawford, D. Dale, 2004 .

Current management of chemotherapy-induced neutropenia: the role of colony-stimulating factors.

David Dale, D. Dale, 2003, Seminars in oncology.

USE OF COLONY-STIMULATING FACTORS FOR TREATMENT OF NEUTROPENIA AND INFECTIOUS DISEASES

D. Dale, L. Quinton, S. Nelson, 1999 .

Differential white blood cell count: underutilized or overrated.

D. Stevens, D. Dale, H. Rosen, 2000, Current opinion in infectious diseases.

Aging and Haemopoiesis

G. Chatta, D. Dale, 1996 .

In vivo effects of recombinant human granulocyte colony-stimulating factor on neutrophil oxidative functions in normal human volunteers.

R. Allen, G. Chatta, D. Dale, 1997, The Journal of infectious diseases.

Myeloid growth factors.

J. Armitage, G. Demetri, G. Lyman, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Aging and haemopoiesis. Implications for treatment with haemopoietic growth factors.

G. Chatta, D. Dale, 1996, Drugs & aging.

Analysis of Factors Associated With In‐hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia

G. Lyman, J. Crawford, D. Dale, 2017, Clinical lung cancer.

Colchicine therapy of familial Mediterranean fever.

D. Alling, C. Dinarello, S. Wolff, 1974, Transactions of the Association of American Physicians.

Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia.

P. Newburger, D. Link, A. Shimamura, 2017, The New England journal of medicine.

CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.

E. R. Sutherland, H. Magnussen, H. Watz, 2015, American journal of respiratory and critical care medicine.

Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy

G. Lyman, J. Crawford, D. Dale, 2005, Cancer.

Achieving a High-Performance Health Care System with Universal Access: What the United States Can Learn from Other Countries

Mark Liebow, David A. Fleming, Molly Cooke, 2008, Annals of Internal Medicine.

Blood phagocyte luminescence: gauging systemic immune activation.

R. Allen, F. Taylor, D. Dale, 2000, Methods in enzymology.

Restructuring an internal medicine residency program to meet regional and national needs for general internists.

J. F. Wallace, R. Petersdorf, D. Dale, 1981, The American journal of medicine.

Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome.

D. Dale, A. Bolyard, Vahagn Makaryan, 2019, Current opinion in hematology.

Current management of chemotherapy-induced neutropenia

D. Dale, 2003 .

A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis

J. Crawford, D. Dale, R. Rifkin, 2022, Supportive Care in Cancer.

Phase I study of a humanized anti‐CD11/CD18 monoclonal antibody in multiple sclerosis

T. Richards, J. Bowen, K. Maravilla, 1998, Clinical pharmacology and therapeutics.

A retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative setting

G. Lyman, J. Crawford, D. Dale, 2013, Breast Cancer Research and Treatment.

Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy

G. Lyman, J. Crawford, D. Dale, 2009, Cancer.

The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action

J. Palmblad, P. Newburger, A. Warren, 2023, HemaSphere.

Inhibition of in vivo neutrophil transmigration by a novel humanized anti-CD11/CD18 monoclonal antibody.

J. Saoud, W. Liles, D. Dale, 2000, Cytokines, cellular & molecular therapy.

Abnormal responsiveness of granulocyte-committed progenitor cells in cyclic neutropenia.

G. Chatta, D. Dale, W. Hammond, 1992, Blood.

Lactoferrin—Specific Localization in the Nuclei of Human Polymorphonuclear Neutrophilic Leukocytes

D. Dale, I. Green, C. Kirkpatrick, 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Repeated lentivirus-mediated granulocyte colony-stimulating factor administration to treat canine cyclic neutropenia.

D. Dale, O. Yanay, W. Osborne, 2012, Human gene therapy.

A risk model for first cycle febrile neutropenia in cancer patients receiving systemic chemotherapy

G. Lyman, J. Crawford, D. Dale, 2005 .

An adult dog with cyclic neutropenia treated by lentivirus- mediated delivery of granulocyte colony-stimulating factor.

D. Liggitt, D. Dale, O. Yanay, 2006, Human Gene Therapy.

Cancer chemotherapy treatment patterns and febrile neutropenia in the US Veterans Health Administration.

O. Baser, D. Dale, W. Langeberg, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Impact of Comorbidities on Length of Stay and Mortality in Hospitalized Patients with Cancer and Febrile Neutropenia

G. Lyman, J. Crawford, D. Dale, 2014 .

Personalizing Cancer Supportive Care: Predicting Neutropenic Complications in Patients Receiving Intermediate Risk Cancer Chemotherapy

G. Lyman, J. Crawford, D. Dale, 2011 .

Outcomes of Pregnancies for Women with Severe Chronic Neutropenia with or without G-CSF Treatment.

P. Rosenberg, P. Newburger, D. Link, 2010 .

The Risk of Low Bone Mineral Density with Long-Term G-CSF Therapy for Severe Chronic Neutropenia.

P. Rosenberg, P. Newburger, D. Link, 2010 .

Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor.

D. Dale, A. Bolyard, E. A. Jones, 1993, JAMA.

Assessing patients’ risk of febrile neutropenia: is there a correlation between physician-assessed risk and model-predicted risk?

G. Lyman, J. Crawford, E. Abella, 2015, Cancer medicine.

30 A risk model for first cycle neutropenic events in older cancer patients receiving systemic chemotherapy

G. Lyman, J. Crawford, D. Dale, 2006 .

Economic analysis of prophylactic granulocyte colony-stimulating factor (G-CSF) use based on a risk model for neutropenic complications in breast cancer patients receiving adjuvant chemotherapy.

G. Lyman, L. Cosler, D. Dale, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Declining interest in internal medicine residencies: A crisis or a quirk?

D. Dale, 1990, Journal of General Internal Medicine.

Gene therapy for long-term expression of erythropoietin in rats.

A. Clowes, D. Dale, W. Osborne, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Colony-stimulating factor in patients with chronic neutropenia.

D. Dale, J. Wewerka, 1976, Blood.

Occurrence of periodic oscillations in the differential blood counts of congenital, idiopathic, and cyclical neutropenic patients before and during treatment with G-CSF.

M. C. Mackey, D. Dale, C Haurie, 1999, Experimental hematology.

Dose Intensity and Hematologic Toxicity in Older Cancer Patients Receiving Systemic Chemotherapy.

G. Lyman, J. Crawford, D. Dale, 2005 .

Comparison of Demographic Characteristics, Surgical Resection Patterns, and Survival Outcomes for Veterans and Nonveterans with Non-small Cell Lung Cancer in the Pacific Northwest

G. Lyman, J. Crawford, D. Au, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Changing Patterns of Chemotherapy Delivery and Supportive Care for Aggressive B-Cell Non-Hodgkin's Lymphoma

G. Lyman, J. Crawford, D. Dale, 2011 .

Use of G-CSF for granulocyte transfusion therapy.

W. Liles, D. Dale, A. Engert, 2000, Cytokines, cellular & molecular therapy.

A new look at an old laboratory test

D. Dale, 1991, Journal of general internal medicine.

A prediction model for chemotherapy-associated thrombocytopenia in cancer patients.

C. Francis, G. Lyman, J. Crawford, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of chemotherapy-induced neutropenia and its complications: results from a prospective nationwide registry.

G. Lyman, J. Crawford, D. Dale, 2005, The journal of supportive oncology.

A Conditional Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

G. Lyman, J. Crawford, D. Dale, 2007 .

Cyclic and chronic neutropenia: an update on diagnosis and treatment.

D. Dale, David C Dale, 2011, Clinical advances in hematology & oncology : H&O.

cyclic neutropenia Mutations in the gene encoding neutrophil elastase in congenital and

K. Welte, M. Horwitz, D. Dale, 2013 .

IMPROVED SURVIVAL FROM GRANULOCYTE-COLONY STIMULATING FACTOR THERAPY FOR CONGENITAL NEUTROPENIA UNMASKS PREDISPOSITION TO MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA

M. Freedman, K. Welte, D. Dale, 1999, Pediatric Research.

Factitious fever and self-induced infection: a report of 32 cases and review of the literature.

A. Fauci, S. Wolff, D. Dale, 1979, Annals of internal medicine.

Granulocyte Transfusions

D. Dale, T. Price, W. Lies, 2000 .

Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis.

A. Fauci, S. Wolff, D. Dale, 1974, Arthritis and rheumatism.

Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia.

A. Ganser, M. Weinblatt, M. Freedman, 1995, Blood.

Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia

J. Palmblad, M. Freedman, A. Veerman, 1997, Leukemia.

Autosomal dominant cyclic hematopoiesis: exclusion of linkage to the major hematopoietic regulatory gene cluster on chromosome 5

E. Wijsman, R. Livingston, K. Stephens, 1994, Human Genetics.

G. Lyman, J. Crawford, D. Dale, 2008 .

Neutrophil-endothelial cell interactions on endothelial monolayers grown on micropore filters.

S. Schwartz, D. Dale, T. Price, 1981, The Journal of clinical investigation.

Neutropenia, inflammation, and the kinetics of transfused neutrophils in rabbits.

D. Dale, T. Price, M. Rosenshein, 1979, The Journal of clinical investigation.

The effect of cyclophosphamide on leukocyte kinetics and susceptibility to infection in patients with Wegener's granulomatosis.

A. Fauci, S. Wolff, D. Dale, 1973, Arthritis and rheumatism.

Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia.

P. Newburger, D. Link, A. Shimamura, 2017, The New England journal of medicine.

Use of Granulocyte Colony-Stimulating Factor During Pregnancy in Women With Chronic Neutropenia

P. Newburger, D. Dale, L. Boxer, 2015, Obstetrics and gynecology.

The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects.

L. Hanson, D. Dale, S. Huyck, 2015, Cytokine.

Preventing Obesity and Its Consequences

Arleen F. Brown, Ariane L. Bedimo-Rung, P. Shekelle, 2011 .

Managing infections in immunosuppressed patients.

D. Dale, H. Featherstone, 1978, Postgraduate medicine.

Understanding, Treating and Avoiding Hematological Disease: Better Medicine Through Mathematics?

M. Mackey, D. Dale, 2014, Bulletin of Mathematical Biology.

Stable Long-Term Risk of Leukemia in Patients with Severe Congenital Neutropenia Maintained On G-CSF Therapy.

P. Rosenberg, P. Newburger, D. Link, 2009 .

Cancer chemotherapy treatment patterns and febrile neutropenia in the US Veterans Health Administration.

O. Baser, D. Dale, W. Langeberg, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

University of Washington School of Medicine.

D. Dale, L. Gray, K. Rodriguez, 1984, The Western journal of medicine.

Department of Medicine, University of Washington School of Medicine, Seattle, Wash.

D. Dale, 1976, Transplantation proceedings.

Comparison of Demographic Characteristics, Surgical Resection Patterns, and Survival Outcomes for Veterans and Nonveterans with Non-small Cell Lung Cancer in the Pacific Northwest

G. Lyman, J. Crawford, D. Au, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Neutropenia Is an Underrecognized Finding in Pediatric Primary Immunodeficiency Diseases: An Analysis of the United States Immunodeficiency Network Registry

D. Dale, E. Garabedian, K. Walkovich, 2020, Journal of pediatric hematology/oncology.